Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.

Balanescu, A

Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients. [electronic resource] - International journal of clinical pharmacology research 2005 - 9-18 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0251-1649


Adult
Antibodies, Monoclonal--administration & dosage
Antigens, CD
Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--blood
CD11c Antigen--biosynthesis
Dendritic Cells--drug effects
Drug Therapy, Combination
Female
Flow Cytometry
Humans
Immunoglobulins--biosynthesis
Infliximab
Male
Membrane Glycoproteins--biosynthesis
Methotrexate--administration & dosage
Middle Aged
Phenotype
Severity of Illness Index
Time Factors
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors
CD83 Antigen